| Product Code: ETC11875567 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
In 2024, Israel continued to import Enoxaparin Sodium primarily from Switzerland, UK, Belgium, USA, and Germany. Despite the low Herfindahl-Hirschman Index (HHI) reflecting low concentration among exporters, the compound annual growth rate (CAGR) for 2020-2024 was -2.14%, indicating a slight decline in import levels. The growth rate from 2023 to 2024 also experienced a negative trend at -0.41%. Overall, the market for Enoxaparin Sodium import shipments to Israel appears stable with diverse sources and modest fluctuations in growth rates.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Enoxaparin Sodium Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Enoxaparin Sodium Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Enoxaparin Sodium Market - Industry Life Cycle |
3.4 Israel Enoxaparin Sodium Market - Porter's Five Forces |
3.5 Israel Enoxaparin Sodium Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Israel Enoxaparin Sodium Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Israel Enoxaparin Sodium Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Israel Enoxaparin Sodium Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Israel Enoxaparin Sodium Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Enoxaparin Sodium Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases and venous thromboembolism in Israel |
4.2.2 Growing geriatric population in Israel requiring anticoagulant therapy |
4.2.3 Rising awareness about the benefits of enoxaparin sodium over traditional anticoagulants |
4.3 Market Restraints |
4.3.1 High cost associated with enoxaparin sodium compared to other anticoagulants |
4.3.2 Stringent regulatory requirements for approval and marketing of enoxaparin sodium in Israel |
4.3.3 Competition from alternative anticoagulant therapies in the market |
5 Israel Enoxaparin Sodium Market Trends |
6 Israel Enoxaparin Sodium Market, By Types |
6.1 Israel Enoxaparin Sodium Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Enoxaparin Sodium Market Revenues & Volume, By Product Type, 2021 - 2031F |
6.1.3 Israel Enoxaparin Sodium Market Revenues & Volume, By Branded, 2021 - 2031F |
6.1.4 Israel Enoxaparin Sodium Market Revenues & Volume, By Generic, 2021 - 2031F |
6.1.5 Israel Enoxaparin Sodium Market Revenues & Volume, By Biosimilar, 2021 - 2031F |
6.2 Israel Enoxaparin Sodium Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Israel Enoxaparin Sodium Market Revenues & Volume, By Deep Vein Thrombosis, 2021 - 2031F |
6.2.3 Israel Enoxaparin Sodium Market Revenues & Volume, By Pulmonary Embolism, 2021 - 2031F |
6.2.4 Israel Enoxaparin Sodium Market Revenues & Volume, By Myocardial Infarction, 2021 - 2031F |
6.3 Israel Enoxaparin Sodium Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Israel Enoxaparin Sodium Market Revenues & Volume, By Subcutaneous, 2021 - 2031F |
6.3.3 Israel Enoxaparin Sodium Market Revenues & Volume, By Intravenous, 2021 - 2031F |
6.3.4 Israel Enoxaparin Sodium Market Revenues & Volume, By Oral, 2021 - 2031F |
6.4 Israel Enoxaparin Sodium Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Israel Enoxaparin Sodium Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 Israel Enoxaparin Sodium Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.4.4 Israel Enoxaparin Sodium Market Revenues & Volume, By Homecare Settings, 2021 - 2031F |
6.5 Israel Enoxaparin Sodium Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Israel Enoxaparin Sodium Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.5.3 Israel Enoxaparin Sodium Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.5.4 Israel Enoxaparin Sodium Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
7 Israel Enoxaparin Sodium Market Import-Export Trade Statistics |
7.1 Israel Enoxaparin Sodium Market Export to Major Countries |
7.2 Israel Enoxaparin Sodium Market Imports from Major Countries |
8 Israel Enoxaparin Sodium Market Key Performance Indicators |
8.1 Number of new prescriptions for enoxaparin sodium in Israel |
8.2 Patient adherence and compliance rates to enoxaparin sodium therapy |
8.3 Number of clinical studies and trials supporting the efficacy and safety of enoxaparin sodium |
9 Israel Enoxaparin Sodium Market - Opportunity Assessment |
9.1 Israel Enoxaparin Sodium Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Israel Enoxaparin Sodium Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Israel Enoxaparin Sodium Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Israel Enoxaparin Sodium Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Israel Enoxaparin Sodium Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Enoxaparin Sodium Market - Competitive Landscape |
10.1 Israel Enoxaparin Sodium Market Revenue Share, By Companies, 2024 |
10.2 Israel Enoxaparin Sodium Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here